DNAPrint Genomics, Inc.
DNAPrint Genomics, Inc. (DNAG) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dnag · pe ratio · data through Dec 31, 2006
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for DNAPrint Genomics, Inc. (DNAG) measures how much investors pay for each dollar of the company's trailing earnings. DNAG's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Source: FMP · /ratios-ttm · /analyst-estimates · 2006-12-31
PE Ratio History
2001 – 2006 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
DNAPrint Genomics, Inc.You DNAG | $0M | N/A | — | -$0.03 |
 AVAX Technologies, Inc. AVXT | $0M | N/A | — | -$0.05 |
 Braxia Scientific Corp. BRAXF | $0M | N/A | — | -$0.06 |
 Interpharm Holdings, Inc. IPAH | $0M | N/A | — | -$0.22 |
 Jack Nathan Medical Corp. JNHMF | $1M | 1.40x | — | $0.03 |
 LadRx Corporation LADX | $0M | N/A | — | -$3210.89 |
 Manhattan Scientifics, Inc. MHTX | $0M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2006-12-31Latest FY2006 | — | $-0.03 | — | |
2005-12-31 FY2005 | — | $-0.09 | — | |
2004-12-31 FY2004 | — | $-0.11 | — | |
2003-12-31 FY2003 | — | $-0.31 | — | |
2002-12-31 FY2002 | — | $-0.14 | — | |
2001-12-31 FY2001 | — | $-0.13 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for DNAPrint Genomics, Inc. (DNAG) measures how much investors pay for each dollar of the company's trailing earnings. DNAG's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Frequently asked questions
DNAG pe ratio · 6 questionsDNAG's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via DNAG's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DNAPrint Genomics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09